@article{908fa1ce387f46159c3fbc23a724b5a9,
title = "Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease",
abstract = "Meta-analyses show that nonbound ceruloplasmin (non-Cp) copper (also known as free or labile copper) in serum is higher in patients with Alzheimer disease (AD). It differentiates subjects with mild cognitive impairment (MCI) from healthy controls. However, a longitudinal study on an MCI cohort has not yet been performed to assess the accuracy of non-Cp copper for the prediction of conversion from MCI to AD during a long-term follow-up.",
keywords = "Alzheimer Disease, Apolipoprotein E4, Ceruloplasmin, Cognition Disorders, Copper, Disease Progression, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Predictive Value of Tests, Probability, Risk Factors, Alzheimer Disease, Apolipoprotein E4, Ceruloplasmin, Cognition Disorders, Copper, Disease Progression, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Predictive Value of Tests, Probability, Risk Factors",
author = "Rosanna Squitti and Roberta Ghidoni and Mariacristina Siotto and Mariacarla Ventriglia and Luisa Benussi and Anna Paterlini and Mariachiara Magri and Giuliano Binetti and Emanuele Cassetta and Deborah Caprara and Fabrizio Vernieri and Rossini, {Paolo Maria} and Patrizio Pasqualetti",
year = "2014",
doi = "10.1002/ana.24136",
language = "English",
volume = "75",
pages = "574--580",
journal = "Annals of Neurology",
issn = "1531-8249",
publisher = "-attuale: WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030 -Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL:
[email protected], INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320",
}